FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/AMGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Amgen, Inc. (AMGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

AMGN trades at $447.50, up 1.88% today and near its 52-week high, supported by a bullish technical signal. The company reported strong Q2 2026 EPS of $6.29, beating estimates, and maintains robust profitability with a 22.95% net margin. Recent positive Phase 3 results for dazodalibep in Sjögren's disease highlight pipeline progress. Cash flow from operations remains healthy at $9.96 billion for 2025, though net cash flow was negative due to financing activities.
The outlook is positive given earnings beats and pipeline advancements, but high debt levels and competitive pressures in biotech pose risks. Analyst consensus is a Buy with a $403.79 price target, suggesting potential downside from current levels. Revenue growth to $38.1 billion in 2026 supports valuation, yet investors should weigh debt management against dividend commitments and R&D investments.
Read full analysis

Key Stats

  • Market Cap
    $240.38B
  • Volume
    2,043,553
  • Sector
    Health
  • 52W High
    $447.28
  • 52W Low
    $291.16
  • Typical Hold Time
    73 Days
  • Enterprise Value
    $283.70B
  • Div Yield
    2.27%
  • Trading Activity
    -
$447.91
52W Low: $291.16
27 Oct 2025
52W High: $447.91
27 Oct 2026

Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $291.16 and a high of $447.91, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Most Recent News

Content is generated by Aura AI

Battery graphite market to grow at 9.5% CAGR, reaching $25.77B by 2036 driven by EV and energy storage demand.

The global battery graphite market, valued at $9.20 billion in 2025, is forecasted to grow at a 9.5% CAGR to $25.77 billion by 2036. This growth is fueled by rising lithium-ion battery production for electric vehicles and energy storage systems, alon...

Market News
1 hour ago
Researchandmarkets.Com
Bullish
news icon
Battery graphite market to grow at 9.5% CAGR, reaching $25.77B by 2036 driven by EV and energy storage demand.

HVAC filters market to reach $6.21B by 2031, driven by rising indoor air quality demand and HEPA tech growth.

The HVAC filters market is projected to grow from USD 4.66 billion in 2026 to USD 6.21 billion by 2031, at a CAGR of 5.9%. This growth is fueled by increasing awareness of indoor air quality, stricter regulations, and expanding infrastructure in cons...

Market News
3 hours ago
Marketsandmarkets
Bullish
news icon
HVAC filters market to reach $6.21B by 2031, driven by rising indoor air quality demand and HEPA tech growth.

Class action lawsuit filed against UP Fintech for alleged securities fraud from 2024-2026 trading period

A class action lawsuit has been filed against UP Fintech Holding Limited, accusing the company of understating legal and regulatory risks related to illegal activities in China. Investors who bought UP Fintech securities between April 22, 2024, and J...

Market News
4 hours ago
GlobeNewsWire
Bearish
news icon
Class action lawsuit filed against UP Fintech for alleged securities fraud from 2024-2026 trading period
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $240.38B
  • Volume
    2,043,553
  • Sector
    Health
  • 52W High
    $447.28
  • 52W Low
    $291.16
  • Typical Hold Time
    73 Days
  • Enterprise Value
    $283.70B
  • Div Yield
    2.27%
  • Trading Activity
    -
$447.91
52W Low: $291.16
27 Oct 2025
52W High: $447.91
27 Oct 2026

Track Amgen, Inc. (AMGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Amgen, Inc. has traded between a low of $291.16 and a high of $447.91, highlighting its annual price range. Buy and sell Amgen, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!